Table 1.
Involved structures and clinical presentation.
| Variable | n (%) |
|---|---|
| Involved structures | n = 989 |
| Eyelids | 160 (16.2%) |
| Orbit | 142 (14.4%) |
| Conjunctiva | 124 (12.5%) |
| Canthus | 79 (8.0%) |
| Sinuses | 59 (6.0%) |
| Face | 41 (4.1%) |
| Lacrimal gland | 37 (3.7%) |
| Choroid | 23 (2.3%) |
| Nose | 22 (2.2%) |
| Unspecified peri-oculus | 19 (2.0%) |
| Periorbital skin | 15 (1.5%) |
| Eye | 14 (1.4%) |
| Cheek | 10 (1.0%) |
| Brain | 9 (0.9%) |
| Supraorbital/brow | 8 (0.8%) |
| Lacrimal sac | 7 (0.7%) |
| Ethmoid bone | 6 (0.6%) |
| Lacrimal duct | 4 (0.4%) |
| Maxilla | 3 (0.3%) |
| Temporal skin | 3 (0.3%) |
| Extraocular muscles | 2 (0.2%) |
| Temple | 2 (0.2%) |
| Alveoli | 1 (0.1%) |
| Nasopharynx | 1 (0.1%) |
| Ophthalmic nerve | 1 (0.1%) |
| Optic nerve | 1 (0.1%) |
| Parotid | 1 (0.1%) |
| Periorbital fat | 1 (0.1%) |
| Others | 194 (19.6%) |
| Presenting signs and symptoms | n = 113 * |
| Disturbed vision | 47 (22.5%) |
| Facial mass | 37 (17.7%) |
| Conjunctival injection | 31 (14.7%) |
| Eye pain | 27 (13.0%) |
| Lesion discharge | 25 (12.0%) |
| Epiphora | 18 (8.6%) |
| Diplopia | 16 (7.7%) |
| Orbital discomfort | 8 (3.8%) |
Data are reported as frequencies and percentages. * The total number of patients with symptoms does not sum up to the number of symptoms as many patients had multiple symptoms.